BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Vitamin E
,
rs3825942
,
FGF21
,
T cell receptor signaling pathway
,
Diabetes mellitus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
c myc
Summary
General Info
Curated Studies
Most Correlated Studies
Induced pluripotent stem cells by direct delivery of Oct4, Sox2, Klf4,and c-Myc proteins
Mammary fibrocystic disease MCF10A cells with HER, c-MYC, or HER plus c-MYC double overexpression
Transcription profiling of lung adenocarcinomas of c-Myc-transgenic mice
Mantle cell lymphoma in Cdk4R24C c-myc-3’RR transgenic mice
Lymphoma gene expression in a transgenic model of c-myc transgene deregulation
Explore Curated Studies Results
Literature
Most Relevant Literature
Evaluation of potential role of R-loop and G-quadruplex DNA in the fragility of c-MYC during chromos…
Critical Role for Cap-Independent c-MYC Translation in Progression of Multiple Myeloma.
Amplifiation of the c-MYC gene in acinar prostate adenocarcinoma. Morphogenic comparisons].
Unbalanced MYC break-apart FISH patterns indicate the presence of a MYC rearrangement in HGBCL-DH-BC…
Solution structures and effects of a platinum compound successively bound MYC G-quadruplex.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Proof-of-concept Study of Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma
Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+…
SPEL as Introductive Treatment Following Immune-chemotherapy as Consolidated Therapy for R/R DLBCL W…
Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma
Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myelo…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ